NYSE: AMWL | Healthcare / Healthcare Providers & Services / USA |
1.30 | +0.0200 | +1.56% | Vol 955.34K | 1Y Perf -62.90% |
Nov 29th, 2023 16:00 DELAYED |
BID | 1.21 | ASK | 1.37 | ||
Open | 1.30 | Previous Close | 1.28 | ||
Pre-Market | 1.31 | After-Market | - | ||
0.01 0.77% | - - |
Target Price | 5.63 | Analyst Rating | Hold 2.71 | |
Potential % | 333.08 | Finscreener Ranking | ★★★★ 53.22 | |
Insiders Trans % 3/6/12 mo. | -100/-100/-100 | Value Ranking | ★★★★ 56.32 | |
Insiders Value % 3/6/12 mo. | -100/-100/-100 | Growth Ranking | ★★★+ 56.02 | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/-100/-100 | Income Ranking | — - | |
Price Range Ratio 52W % | 11.19 | Earnings Rating | — | |
Market Cap | 373.84M | Earnings Date | 1st Nov 2023 | |
Alpha | -0.07 | Standard Deviation | 0.18 | |
Beta | 0.90 |
Today's Price Range 1.261.39 | 52W Range 0.92514.28 |
Summary:
Neutral
Technical Indicators: | Neutral |
Moving Averages: | Buy |
Performance | |||
---|---|---|---|
1 Week | 10.17% | ||
1 Month | 15.04% | ||
3 Months | -12.16% | ||
6 Months | -41.18% | ||
1 Year | -62.90% | ||
3 Years | -95.10% | ||
5 Years | - | ||
10 Years | - |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | - | |||
ROE last 12 Months | -21.78 | |||
ROA (5Y Avg) | - | |||
ROA last 12 Months | -18.93 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | -21.47 | |||
Return on invested Capital Q | -6.28 | |||
Return on invested Capital Y | -14.19 | |||
Assets Turnover | 0.10 | |||
Receivables Turnover | 1.90 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
-3.50 | ||||
0.85 | ||||
4.14 | ||||
- | ||||
-5.80 | ||||
-0.74 | ||||
1.72 | ||||
3.94 | ||||
351.34M | ||||
Forward PE | - | |||
PEG | - |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
6.00 | ||||
6.30 | ||||
0.01 | ||||
0.01 | ||||
-638.80 | ||||
Leverage Ratio | 1.10 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
34.20 | ||||
-95.50 | ||||
-85.70 | ||||
- | ||||
-95.45 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
197.96M | ||||
0.82 | ||||
18.28 | ||||
- |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
- | ||||
- | ||||
Payout ratio | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q03 2023 | -0.20 | -0.20 | 0.00 |
Q02 2023 | -0.21 | -0.23 | -9.52 |
Q01 2023 | -0.20 | -0.24 | -20.00 |
Q04 2022 | -0.25 | -0.22 | 12.00 |
Q03 2022 | -0.26 | -0.25 | 3.85 |
Q02 2022 | -0.25 | -0.25 | 0.00 |
Q01 2022 | -0.22 | -0.26 | -18.18 |
Q04 2021 | -0.28 | -0.18 | 35.71 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
- | - | - | - |
- | - | - | - |
- | - | - | - |
- | - | - | - |
Next Report Date | - |
Estimated EPS Next Report | -0.20 |
Estimates Count | 6 |
EPS Growth Next 5 Years % | - |
Volume Overview | |
---|---|
Volume | 955.34K |
Shares Outstanding | 287.57K |
Shares Float | 242.13M |
Trades Count | 7.17K |
Dollar Volume | 1.26M |
Avg. Volume | 1.56M |
Avg. Weekly Volume | 890.39K |
Avg. Monthly Volume | 2.16M |
Avg. Quarterly Volume | 1.63M |
American Well Corporation Class A (NYSE: AMWL) stock closed at 1.3 per share at the end of the most recent trading day (a 1.56% change compared to the prior day closing price) with a volume of 955.34K shares and market capitalization of 373.84M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 686 people. American Well Corporation Class A CEO is Roy Schoenberg / Ido Schoenberg.
The one-year performance of American Well Corporation Class A stock is -62.9%, while year-to-date (YTD) performance is -54.06%. AMWL stock has a five-year performance of %. Its 52-week range is between 0.9251 and 4.275, which gives AMWL stock a 52-week price range ratio of 11.19%
American Well Corporation Class A currently has a PE ratio of -3.50, a price-to-book (PB) ratio of 0.85, a price-to-sale (PS) ratio of 4.14, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -18.93%, a ROC of -21.47% and a ROE of -21.78%. The company’s profit margin is -95.45%, its EBITDA margin is -85.70%, and its revenue ttm is $197.96 Million , which makes it $0.82 revenue per share.
Of the last four earnings reports from American Well Corporation Class A, there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.20 for the next earnings report. American Well Corporation Class A’s next earnings report date is -.
The consensus rating of Wall Street analysts for American Well Corporation Class A is Hold (2.71), with a target price of $5.63, which is +333.08% compared to the current price. The earnings rating for American Well Corporation Class A stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
American Well Corporation Class A has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
American Well Corporation Class A has a Neutral technical analysis rating based on Technical Indicators (ADX : 18.27, ATR14 : 0.12, CCI20 : 57.51, Chaikin Money Flow : -0.09, MACD : 0.03, Money Flow Index : 50.71, ROC : 14.04, RSI : 54.44, STOCH (14,3) : 58.33, STOCH RSI : 0.53, UO : 47.16, Williams %R : -41.67), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of American Well Corporation Class A in the last 12-months were: Amber Howe (Sold 1 635 shares of value $6 328 ), Bradford Gay (Sold 55 967 shares of value $211 982 ), Gotlib Phyllis (Sold 83 632 shares of value $201 986 ), Ido Schoenberg (Sold 0 shares of value $0 ), Ido Schoenberg (Sold 957 657 shares of value $2 157 661 ), Jackson Deborah (Sold 2 376 shares of value $2 946 ), Jackson Deborah C (Sold 23 173 shares of value $58 178 ), Knight Kurt (Sold 142 597 shares of value $354 494 ), Kurt Knight (Sold 75 715 shares of value $259 627 ), McNeice Paul Francis (Sold 620 shares of value $1 309 ), Paul Francis Mcneice (Sold 6 516 shares of value $15 906 ), Peter Slavin (Sold 35 000 shares of value $96 027 ), Phyllis Gotlib (Sold 60 939 shares of value $186 444 ), Robert Shepardson (Sold 121 845 shares of value $361 102 ), Roy Schoenberg (Sold 246 793 shares of value $708 146 ), Schoenberg Roy (Sold 0 shares of value $0 ), Schoenberg Roy (Sold 624 894 shares of value $1 246 406 ), Serkan Kutan (Sold 21 347 shares of value $80 308 ), Shepardson Robert (Sold 116 974 shares of value $283 906 ), Slavin Peter L. (Sold 22 670 shares of value $56 920 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Hold | Hold | Hold |
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, enables care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations.
CEO: Roy Schoenberg / Ido Schoenberg
Telephone: +1 617 204-3500
Address: 75 State Street, Boston 02109, MA, US
Number of employees: 686
Thu, 02 Nov 2023 22:00 GMT Analysts Have Conflicting Sentiments on These Healthcare Companies: American Well (AMWL), BridgeBio Pharma (BBIO) and Idexx Laboratories (IDXX)
- TipRanks. All rights reserved.Wed, 25 Oct 2023 10:01 GMT Analysts Are Neutral on Top Healthcare Stocks: American Well (AMWL), Edwards Lifesciences (EW)
- TipRanks. All rights reserved.Sat, 21 Oct 2023 13:31 GMT Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), American Well (AMWL) and Merck & Company (MRK)
- TipRanks. All rights reserved.Mon, 07 Aug 2023 09:31 GMT Analysts Offer Insights on Healthcare Companies: American Well (AMWL) and Idexx Laboratories (IDXX)
- TipRanks. All rights reserved.Wed, 19 Jul 2023 02:25 GMT American Well (AMWL) Receives a Hold from Truist Financial
- TipRanks. All rights reserved.Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.
General partner of Finscreener is SLOVAKODATA, a.s.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.